Patent Applications published on Mar 28, 2024

Explore the 8,758 U.S. Patent Applications published on the 13th week of 2024, including 24 applications that subsequently received a Patent Grant.

Featured patent applications from Mar 28, 2024

Published: 2024-03-28 Assignee: Moderna TX, Inc..
US20240100145A1
Human necessities
Application 20240100145, fig. 01

VLP ENTEROVIRAL VACCINES

Messenger RNA vaccines have been developed to protect against enteroviruses by encoding specific proteins that trigger an immune response. These vaccines contain RNA molecules that encode proteins responsible for building the outer shell of the virus and a protease enzyme. Additionally, the vaccines may include RNA molecules that can alter the expression or function of other RNA molecules within the body.

Published: 2024-03-28 Assignee: APPLE INC..
US20240106975A1
Electricity
Application 20240106975, fig. 01

Collaborative Video Recording

A system has been created for collaborative video recording, where multiple recording devices can work together. The system uses a reference clock to keep track of time and provides a synchronization code to all devices. This allows the devices to record videos simultaneously and create a shared timeline with synchronized timestamps.

Published: 2024-03-28 Assignee: Microsoft Technology Licensing, LLC.
US20240103646A1
Physics
Application 20240103646, fig. 01

UNIVERSAL HIGHLIGHTER FOR CONTEXTUAL NOTETAKING

This invention allows users to highlight information on a screen and automatically gather related context data for taking notes. It can capture content from windows and applications, determine the context, and generate notes based on the highlighted information. By simplifying the notetaking process and providing enriched data based on context, this technology helps users create and access notes more efficiently.

Published: 2024-03-28
US20240101957A1
Chemistry; metallurgy
Application 20240101957, fig. 01

METHODS AND COMPOSITIONS FOR GENERATING EMBRYOS IN VITRO FROM PLURIPOTENT STEM CELLS

A method has been developed to create synthetic embryos in a lab using pluripotent stem cells. By combining regular stem cells with modified ones containing specific genes, these cells can self-organize into embryo structures. This technology can be used to generate human embryos from pluripotent embryonic stem cells.

Published: 2024-03-28
US20240101718A1
Chemistry; metallurgy

ANTI-PD-1/LAG-3 BISPECIFIC ANTIBODIES AND USES THEREOF

A new type of antibody has been created to fight advanced cancers like melanoma and head and neck squamous cell carcinoma. This antibody targets two specific proteins, PD-1 and LAG-3, to enhance the body's immune response against these types of cancer. The invention aims to improve treatment options for patients with these challenging malignancies.

Published: 2024-03-28
US20240107256A1
Electricity
Application 20240107256, fig. 01

AUGMENTED REALITY SPATIAL AUDIO EXPERIENCE

An eyewear device with spatial audio technology creates an immersive augmented reality experience. It captures images of the surroundings, identifies objects, and overlays virtual objects in the real world. The device tracks the user's position and uses audio signals to guide them towards the identified objects in the environment.

Published: 2024-03-28
US20240101645A1
Chemistry; metallurgy
Application 20240101645, fig. 01

MONOCLONAL ANTIBODIES AGAINST CORONAVIRUSES AND USES THEREOF

Monoclonal antibodies have been created to target the spike proteins found on different types of coronaviruses, including SARS-CoV-2. These antibodies can effectively bind to specific parts of the spike protein and show potential to work against various coronaviruses. The invention includes not only the antibodies themselves but also methods for diagnosing, preventing, and treating coronavirus infections, particularly those caused by SARS-CoV-2.

Published: 2024-03-28 Assignee: APPLE INC..
US20240102712A1
Mechanical engineering
Application 20240102712, fig. 01

DECOUPLED AND COORDINATED CONTROL OF REFRIGERATION CLIMATE CONTROL SYSTEMS

These techniques help multiple refrigeration systems work together efficiently. They gather climate control data and receive signals about the energy source. Then, they create control signals for each system to operate optimally using the available electricity.

Published: 2024-03-28
US20240100149A1
Human necessities
Application 20240100149, fig. 01

SARS-COV-2 CONSTRUCTS, VACCINES, AND METHODS

An antibody that fights against a specific immune system protein is combined with a part of the SARS-CoV-2 virus. This combination is used to create a vaccine for treating and preventing SARS-CoV-2 infection. The vaccine does not contain any additional substances to enhance its effectiveness.

Published: 2024-03-28 Assignee: ARBOR BIOTECHNOLOGIES, INC..
US20240102007A1
Chemistry; metallurgy
Application 20240102007, fig. 01

GENE EDITING SYSTEMS COMPRISING A CRISPR NUCLEASE AND USES THEREOF

A gene editing system has been developed using a Type V CRISPR nuclease, a reverse transcriptase (RT), guide RNA (gRNA), and reverse transcription donor RNA (RT donor RNA). The gRNA contains binding sites for the CRISPR nuclease and a specific spacer sequence for targeting a genomic site of interest. The RT donor RNA includes a primer binding site and template sequence for facilitating gene editing processes.